CD44 and small cell lung carcinoma: The SCLC cell line NCI-H446 exhibits a high degree of stemness, tumorigenicity and plasticity correlated to expression of CD133, Sall4, Oct-4, nestin, neural cell adhesion molecule (NCAM), S100β, vimentin, CD44 and CD105 [64].